iOnctura expands Advisory Board
27 sept. 2022 02h00 HE
|
iOnctura
Geneva, Switzerland, 27 September 2022 -- iOnctura SA, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways,...
3B Future Health Fund announces new investment in iOnctura
14 juil. 2020 03h00 HE
|
Helsinn Healthcare S.A.
3B Future Health Fund announces new investment in iOnctura MONACO, PRINCIPALITY OF MONACO, July 14, 2020: 3B Future Health Fund, previously known as Helsinn Investment Fund S.A., SICAR, today...